IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CSF2 (COLONY STIMULATING FACTOR 2 (GRANULOCYTE-MACROPHAGE), GRANULOCYTEMACROPHAGE COLONY STIMULATING FACTOR, GM-CSF)), HOMO SAPIENS MONOCLONAL ANTIBODY
Relapsed/Refractory Large B-cell Lymphoma
Kite, A Gilead Companymonoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
108 Active assets in the Relapsed/Refractory Large B-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Selinexor Chengdu Zenitar Biomedical Technology Co., Ltd | Phase 3 | BB |
DEXAMETHASONE City of Hope Medical Center | Phase 2/3 | BB |
Ifosfamide University of California, Davis | Phase 3 | BB |
Cyclophosphamide Nathan Denlinger | Phase 3 | BB |
Axicabtagene Ciloleucel Zhujiang Hospital | Phase 3 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →